top of page

Funding Opportunities for Breakthrough Innovation

ATXA Therapeutics Founder and CSO, Prof Therese Kinsella will represent the company at an event on the European Innovation Council Funding Opportunities for Breakthrough Innovation. This event is hosted by the European Commission Representation in Ireland and will take place on Friday 3rd May 2019.

The European Innovation Council (EIC) will offer €2bn for the financing of disruptive, market-creating innovation in its pilot phase between 2019-2020, in view of setting up a fully-fledged EIC under the next EU budget (2021-2027).

https://ec.europa.eu/ireland/events_en

 
 
 
Small Logo Gray.jpg

© 2025 ATXA Therapeutics Ltd. All Rights Reserved.

  • LinkedIn
  • X
  • Facebook
  • YouTube

TERMS OF USE

PRIVACY POLICY

Company number: 561857

UCD Conway Institute,

University College Dublin,

Belfield, Dublin 4, Ireland

Tel: +353 (0)1 525 2829

Contact Us

bottom of page